News

Drug Shortage Impact - PLEASE Share Your Stories!

Help ASCO help us with legislation changes!

Details >

ASCO's Practice Impact Analysis of 2024 Medicare Physician Fee Schedule Proposed Rule

Details >

Join OHOS in Supporting House Bill 130!

Prior Authorization Gold Card Program

Details >

HHS Selects the First Drugs for Medicare Drug Price Negotiation

Details >

A September Message From OHOS Lobbyist, Matt Whitehead

This is a must read!!

Details >

Physician Fee Schedule Proposed Rule Cuts Radiation Oncology Services by 2%

ASTRO Leaders See Cuts to Radiation Therapy Services Hitting Patient Access

Details >

An August Message From OHOS Lobbyist, Matt Whitehead

Includes important information on the August 8th election!

Details >

What Happened to Ohio's Co-Pay Accumulator Bill?

Details >

ASCO in Action - Comments on Release of 2024 OPPS and PFS Proposed Rules

Physician Fee Schedule Conversion Factor Cut to 3.36%

Details >

CMS Physician Fee Schedule and Outpatient Hospital Proposed Rules Released!

Details >

ASTRO Releases New Radiation Oncology Payment Reform Legislative Proposal

Town Hall on July 21st for Radiation Oncology Community

Details >

CMS Announces Actions to Lower Health Care Costs and Allow Medicare to Negotiate Lower Drug Prices

Details >

A July Message From OHOS Lobbyist, Matt Whitehead

An update about White-Bagging, Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!

Details >

OHOS Regional Spring Meeting Roundtables

A Great Success That Has Ignited Many OHOS Initiatives!

Details >

COA - Statement on CMS Failure to Rescind FAQ Barring Oncology Practices from Delivering Cancer Drugs to Their Patients

Details >

DELAYED - New CIGNA Reimbursement Policy on Modifier 25

Details >

CNBC - FDA Allows Temporary Import of Unapproved Chinese Cancer Drug to Ease US Shortage

Details >

ASCO - National Shortage of Cancer Drugs Updates

Guidance for Clinicians on GI Cancer, Recommendations to Policymakers, Dedicated Drug Shortages Website

Details >

A June Message From OHOS Lobbyist, Matt Whitehead

An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!

Details >

OHOS Supports the "Safe Step Act" Legislation

Ensures that employer health plans and pharmacy benefit managers (PBMs) provide an expedient and medically reasonable step therapy exceptions process.

Details >

Practices Ask HHS Secretary Becerra and Congress for Stark Law Fix

Details >

2024 Medicare Advantage, Part D Final Rule Addresses Prior Authorization, Equity and Affordability

Details >

HHS Notice of Benefit and Payment Parameters for 2024

Details >

New House Bill Aims to Help Stabilize Medicare Physician Reimbursement, Patient Access to Care

Details >

Cancer Doctors Call on Congress to Reduce Barriers to Care and Support Cancer Research

Details >

A May Message From OHOS Lobbyist, Matt Whitehead

An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and so much more!

Details >

Ohio Bill Seeks to Get Coverage for Biomarker Testing Under Insurance Companies

Details >

HHS Releases National Cancer Plan

Details >

Shortages of 4 Drugs May Complicate Cancer Care

Includes methotrexate, cisplatin and fluorouracil

Details >

Ohio Attorney General, David Yost, Sues Express Scripts, Prime Therapeutics and 5 Others, Blaming Exorbitant Drug Prices on Their Collusion

Details >

Reduced Beneficiary Coinsurance for 27 Part B Drugs in Effect April 1st - Includes Cancer Drugs

Details >

HHS Updates 2024 Medicare Advantage Program and Part D Payment Policies

Details >

An April Message From OHOS Lobbyist, Matt Whitehead

An update about Prior Authorizations, Biomarker Testing, Copay Accumulator Bills and more!

Details >

HHS Releases Initial Guidance for Historic Medicare Drug Price Negotiation Program for Price Applicability Year 2026

Details >

Timeline for Unwinding the COVID-19 Public Health Emergency

Details >

Estimated Impact of 2023 Medicare Physician Reimbursement Cuts Now -1% for Hematology/Oncology

Details >

Legislation to Increase PBM Transparency and Lower Out-of-Pocket Costs Introduced in Congress

Details >

The End of the Public Health Emergency - What Goes and What Doesn't

Details >

COVID-19 Public Health Emergency Ending May 11, 2023

Details >